SPECT and PET Serve as Molecular Imaging Techniques and in Vivo Biomarkers for Brain Metastases
Nuclear medicine techniques (single photon emission computerized tomography, SPECT, and positron emission tomography, PET) represent molecular imaging tools, able to provide in vivo biomarkers of different diseases. To investigate brain tumours and metastases many different radiopharmaceuticals imag...
Main Authors: | Barbara Palumbo, Tommaso Buresta, Susanna Nuvoli, Angela Spanu, Orazio Schillaci, Mario Luca Fravolini, Isabella Palumbo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/15/6/9878 |
Similar Items
-
A prospective study determining and comparing the diagnostic accuracy of fluoride-PET/CT, choline-PET/CT, whole-body bone SPECT/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer
by: Eva Dyrberg, et al.
Published: (2018-10-01) -
PET/CT Radiomics in Lung Cancer: An Overview
by: Francesco Bianconi, et al.
Published: (2020-03-01) -
PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology
by: Sara S. Rinne, et al.
Published: (2021-04-01) -
Bispecific GRPR-Antagonistic Anti-PSMA/GRPR Heterodimer for PET and SPECT Diagnostic Imaging of Prostate Cancer
by: Bogdan Mitran, et al.
Published: (2019-09-01) -
Silicon Detectors for PET and SPECT
by: Cochran, Eric R.
Published: (2010)